Tirzepatide 20mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This pharmaceutical-grade compound is supplied as a white powder with purity exceeding 99%, making it ideal for research applications.
As a GLP-1 analog, tirzepatide 20mg demonstrates superior metabolic effects compared to single agonists. The compound has shown promising results in glucose control and weight management studies. Our tirzepatide 20mg is manufactured under strict quality control standards to ensure batch-to-batch consistency.
The product is available in various packaging options including vials of 5mg, 10mg, 20mg, and 30mg. Custom formulations and packaging solutions are available for bulk orders. Each batch of tirzepatide 20mg is accompanied by comprehensive analytical documentation.
For research purposes only. Not for human consumption. Proper storage conditions are essential to maintain the stability of tirzepatide 20mg. The product should be stored at controlled temperatures between 2-8°C for short-term use or at -20°C for long-term preservation.
Our facility specializes in the production of high-quality tirzepatide 20mg for research institutions and pharmaceutical developers. With advanced synthesis technology and rigorous quality control, we ensure the highest standards for this important metabolic research compound.